Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APLANTUS: Apremilast in Moderate to Severe Palmoplantar Pustulosis
2016-005122-11Phase 2Completed
- Sponsor
- Prof. Dr. Kristian Reich
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of apremilast in Palmoplantar Pustular Psoriasis (PPPP), sponsored by Prof. Dr. Kristian Reich. Primary endpoint: Primary: Percent change in PPPASI at week 20. Started Nov 2017; status: completed.
02
Drugs
apremilast
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)
Beyond the preview
Go deeper on 2016-005122-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005122-11.